Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Dapagliflozin reduced the risk of all-cause mortality or worsening heart failure by 28% in patients with aortic stenosis ...

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...

Enzo Cornejo tells the anaesthetists he wants to know exactly when they are going to put him to sleep. There’s something ...

Catheter ablation beat weight loss and antiarrhythmic drugs for reducing recurrent atrial fibrillation in patients with ...

THE ANNUAL world-leading course in interventional cardiology, the European Association of Percutaneous Cardiovascular ...

Objective: To establish a classification of bicuspid aortic valve (BAV) that includes both leaflet morphology and aortic shape. Setting: Two academic medical centres of the University of Washington, ...

Cusp overlap view improved valve positioning and significantly reduced pacemaker need, and hospital stay in TAVR with SEVs.

MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

Permanent pacemaker rates were nearly 18% at 30 days but came down as sites gained experience with the new device.

Currently, cardiovascular specialists from the 108 Military Central Hospital are working alongside a team of Prof.Dr. Jan D.

Severely stenosed bicuspid aortic valves are very rigid because of fibrosis and heavy calcification, but are not narrowed. 8 20 23 Both calcification and fibrosis (and thus deteriorating valve ...